Jaume Mora

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Advanced Non Small Cell Lung Cancer

Acute Lymphoblastic Leukemia

Endoplasmic Reticulum Stress

Top Venues

Pediatric blood & cancer

Children (Basel, Switzerland)

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Maite Gorostegui, Juan Pablo Muñoz, Sara Perez-Jaume, Margarida Simao-Rafael, Cristina Larrosa, Moira Garraus, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe, Alicia Castañeda, Jaume Mora
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy. Cancers 16 (9) (2024)
Albert Pasten, Cristina Salvador Alarcón, Jaume Mora, Marta P Martín Gimenez, Rosalia Carrasco Torrents, Lucas Krauel
Current Status of Fertility Preservation in Pediatric Oncology Patients. Children (Basel, Switzerland) 11 (5) (2024)
Maite Gorostegui, Juan Pablo Muñoz, Sara Perez-Jaume, Margarida Simao-Rafael, Cristina Larrosa, Moira Garraus, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe, Alicia Castañeda, Jaume Mora
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy. Cancers 16 (9) (2024)
Albert Pasten, Cristina Salvador Alarcón, Jaume Mora, Marta P Martín Gimenez, Rosalia Carrasco Torrents, Lucas Krauel
Current Status of Fertility Preservation in Pediatric Oncology Patients. Children (Basel, Switzerland) 11 (5) (2024)
Juan Pablo Muñoz, Cristina Larrosa, Saray Chamorro, Sara Perez-Jaume, Margarida Simao, Nazaret Sanchez-Sierra, Amalia Varo, Maite Gorostegui, Alicia Castañeda, Moira Garraus, Sandra Lopez-Miralles, Jaume Mora
Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes. Cancers 15 (19) (2023)
Cristina Larrosa, Jaume Mora, Nai Kong V Cheung
Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2. Cancers 15 (14) (2023)
Jaume Mora, Alicia Castañeda, Maite Gorostegui, Amalia Varo, Sara Perez-Jaume, Margarida Simao, Juan Pablo Muñoz Pérez, Moira Garraus, Cristina Larrosa, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report. Cancers 15 (9) (2023)
Ignacio Reinal, Imelda Ontoria-Oviedo, Marta Selva, Marilù Casini, Esteban Peiró-Molina, Carlos Fambuena-Santos, Andreu M Climent, Julia Balaguer, Adela Cañete, Jaume Mora, Ángel Raya, Pilar Sepúlveda
Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs. Antioxidants (Basel, Switzerland) 12 (7) (2023)
Rosario Aschero, Helena Castillo-Ecija, Merce Baulenas-Farres, Claudia Resa-Pares, Ana Jimenez-Cabaco, Eva Rodriguez, Carles Monterrubio, Sara Perez-Jaume, Mariona Suñol, Guillermo L Chantada, Cinzia Lavarino, Jaume Mora, Angel Montero Carcaboso
Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma. Pediatric blood & cancer (2023)
Jaume Mora, Alicia Castañeda, Maite Gorostegui, Amalia Varo, Sara Perez-Jaume, Margarida Simao, Juan Pablo Muñoz Pérez, Moira Garraus, Cristina Larrosa, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report. Cancers 15 (9) (2023)
Rosario Aschero, Daiana Ganiewich, Gabriela Lamas, Camilo A Restrepo-Perdomo, Daniela Ottaviani, Santiago Zugbi, Sandra Camarero, Ezequiel Néspoli, Maria Cuadrado Vilanova, Sara Perez-Jaume, Guillem Pascual-Pasto, Claudia Sampor, Nathalia Grigorovski, Beatriz Salas, Mariona Suñol, Angel M Carcaboso, Jaume Mora, María T G de Dávila, François Doz, François Radvanyi, David H Abramson, Andrea S Llera, Paula S Schaiquevich, Fabiana Lubieniecki, Guillermo L Chantada
Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma. Pediatric blood & cancer (2023)
Jaume Mora, Godfrey Chi Fung Chan, Daniel A Morgenstern, Karsten Nysom, Melissa K Bear, Karen Tornøe, Brian H Kushner
Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse events. Cancer reports (Hoboken, N.J.) (2022)
Jaume Mora, Alicia Castañeda, Maite Gorostegui, Vicente Santa-María, Moira Garraus, Juan Pablo Muñoz, Amalia Varo, Sara Perez-Jaume, Salvador Mañe
Naxitamab combined with granulocyte-macrophage colony-stimulating factor as consolidation for high-risk neuroblastoma patients in complete remission. Pediatric blood & cancer 68 (10) (2021)
Riyue Bao, Anita Ng, Mark Sasaki, Myvizhi Esai Selvan, Alyna Katti, Hyesan Lee, Lei Huang, Andrew D Skol, Cinzia Lavarino, Hector Salvador, Robert J Klein, Zeynep Hülya Gümüş, Jaume Mora, Kenan Onel
Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility. Cancer prevention research (Philadelphia, Pa.) 14 (4) (2021)
Jaume Mora, Alicia Castañeda, Maria Cecilia Colombo, Maite Gorostegui, Fernando Gómez Muñoz, Salvador Mañe, Vicente Santa-Maria, Moira Garraus, Napoleon Macias, Sara Perez-Jaume, Oscar Muñoz, Juan Pablo Muñoz Pérez, Ignasi Barber, Mariona Suñol
Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma. Cancers 13 (6) (2021)
Rosario Aschero, Jasmine H Francis, Daiana Ganiewich, Soledad Gómez-González, Claudia Sampor, Santiago Zugbi, Daniela Ottaviani, Lauriane Lemelle, Marcela Mena, Ursula Winter, Genoveva Correa Llano, Gabriela Lamas, Fabiana Lubieniecki, Irene Szijan, Jaume Mora, Osvaldo Podhajcer, François Doz, François Radvanyi, David H Abramson, Andrea Sabina Llera, Paula S Schaiquevich, Cinzia Lavarino, Guillermo L Chantada
Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma. Cancers 13 (4) (2021)
Sara Sánchez-Molina, Elisabet Figuerola-Bou, Enrique Blanco, María Sánchez-Jiménez, Pablo Táboas, Soledad Gómez-González, Cecilia Ballaré, Daniel José García-Domínguez, Estela Prada, Lourdes Hontecillas-Prieto, Angel Montero Carcaboso, Òscar Martínez Tirado, Inmaculada Hernández-Muñoz, Enrique de Álava, Cinzia Lavarino, Luciano Di Croce, Jaume Mora
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis. Science advances 6 (43) (2020)
Kathleen I Pishas, Christina D Drenberg, Cenny Taslim, Emily R Theisen, Kirsten M Johnson, Ranajeet S Saund, Ioana L Pop, Brian D Crompton, Elizabeth R Lawlor, Franck Tirode, Jaume Mora, Olivier Delattre, Mary C Beckerle, David F Callen, Sunil Sharma, Stephen L Lessnick
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response. Molecular cancer therapeutics 17 (9) (2018)
Pilar Puerto-Camacho, Ana Teresa Amaral, Salah-Eddine Lamhamedi-Cherradi, Brian A Menegaz, Helena Castillo-Ecija, José Luis Ordóñez, Saioa Domínguez, Carmen Jordan-Perez, Juan Diaz-Martin, Laura Romero-Pérez, Maria Lopez-Alvarez, Gema Civantos-Jubera, María José Robles-Frías, Michele Biscuola, Cristina Ferrer, Jaume Mora, Branko Cuglievan, Keri Schadler, Oliver Seifert, Roland Kontermann, Klaus Pfizenmaier, Laureano Simón, Myriam Fabre, Ángel M Carcaboso, Joseph A Ludwig, Enrique de Álava
Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (7) (2018)
Yang-Yang Ding, Jessica Panzer, John M Maris, Alicia Castañeda, Marta Gomez-Chiari, Jaume Mora
Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma: A case series. Pediatric blood & cancer 65 (1) (2017)